Petros Pharmaceuticals, Inc. SEC filings PTPI
Petros Pharmaceuticals, Inc. has 257 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (bankruptcy, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Feb 19, 2025 | — |
| S-1MEF | Filing | Feb 14, 2025 | — |
| S-1/A | Amended registration statement | Feb 14, 2025 | — |
| S-1/A | Amended registration statement | Feb 13, 2025 | — |
| S-1/A | Amended registration statement | Feb 10, 2025 | — |
| S-1 | Registration statement | Jan 24, 2025 | — |
| S-3 | Shelf registration | May 3, 2024 | — |
| 424B3 | Prospectus | Sep 19, 2023 | — |
| S-3/A | Form s-3/a | Sep 15, 2023 | — |
| S-3 | Shelf registration | Aug 11, 2023 | — |
| S-8 | Employee stock plan registration | Dec 22, 2022 | — |
| POS AM | Filing | Oct 14, 2022 | — |
| 424B3 | Prospectus | Jan 14, 2022 | — |
| S-1 | Registration statement | Jan 6, 2022 | — |
| 424B5 | Prospectus supplement | Dec 23, 2021 | — |
| 424B3 | Prospectus | Dec 20, 2021 | — |
| S-1 | Registration statement | Dec 13, 2021 | — |
| 424B5 | Prospectus supplement | Dec 1, 2021 | — |
| 424B3 | Prospectus | Nov 23, 2021 | — |
| S-1 | Registration statement | Nov 12, 2021 | — |
| 424B5 | Prospectus supplement | Oct 15, 2021 | — |
| S-3 | Shelf registration | Jan 29, 2021 | — |
| S-8 | Employee stock plan registration | Jan 22, 2021 | — |
| 424B3 | Prospectus | Nov 2, 2020 | — |
| S-4/A | Filing | Oct 28, 2020 | — |
| S-4/A | Filing | Oct 21, 2020 | — |
| S-4/A | Filing | Oct 15, 2020 | — |
| S-4/A | Filing | Sep 30, 2020 | — |
| S-4 | Registration for a merger or exchange | Jul 24, 2020 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTPI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1815903
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.